US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 7.210
- -0.110-1.50%
Close Nov 4 16:00 ET
- 7.330
- +0.120+1.66%
Post 16:23 ET
1.03BMarket Cap-20600P/E (TTM)
7.280High7.030Low1.20MVolume7.280Open7.320Pre Close8.59MTurnover0.93%Turnover RatioLossP/E (Static)142.99MShares10.05052wk High2.83P/B927.06MFloat Cap4.71052wk Low--Dividend TTM128.58MShs Float33.972Historical High--Div YieldTTM3.42%Amplitude1.000Historical Low7.180Avg Price1Lot Size
Aurinia Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 37.83%57.19M | 46.19%50.3M | 30.95%175.51M | 58.59%45.1M | -2.27%54.52M | 47.19%41.49M | 59.12%34.41M | 193.89%134.03M | 21.50%28.44M | 280.30%55.78M |
| Operating revenue | 37.83%57.19M | 46.19%50.3M | 30.95%175.51M | 58.59%45.1M | -2.27%54.52M | 47.19%41.49M | 59.12%34.41M | 193.89%134.03M | 21.50%28.44M | 280.30%55.78M |
| Cost of revenue | 469.99%8.91M | 1,741.33%7.75M | 149.79%14.15M | 296.11%5.4M | 176.62%6.77M | -2.25%1.56M | 64.45%421K | 419.16%5.66M | 183.16%1.36M | 863.39%2.45M |
| Gross profit | 20.92%48.28M | 25.19%42.55M | 25.71%161.37M | 46.64%39.7M | -10.47%47.75M | 50.16%39.93M | 59.05%33.99M | 188.37%128.37M | 18.10%27.07M | 270.03%53.33M |
| Operating expense | -13.15%48.72M | -22.73%49.12M | 5.51%253.06M | 25.74%69.37M | 1.87%64.01M | -10.35%56.1M | 7.29%63.57M | 6.48%239.84M | -0.82%55.17M | -2.99%62.83M |
| Selling and administrative expenses | -3.12%42.28M | -3.13%44.85M | -0.68%195.04M | 5.47%50.07M | -8.45%47.76M | -15.31%43.64M | 2.44%46.3M | 13.16%196.37M | 6.05%47.47M | 16.85%52.17M |
| -General and administrative expense | -3.12%42.28M | -3.13%44.85M | -0.68%195.04M | 5.47%50.07M | -8.45%47.76M | -15.31%43.64M | 2.44%46.3M | 13.16%196.37M | 6.05%47.47M | 16.85%52.17M |
| Research and development costs | -67.75%4.08M | -57.81%5.55M | 10.34%49.64M | 3.63%10.23M | 23.99%13.61M | 9.76%12.65M | 4.26%13.16M | -12.03%44.99M | -11.47%9.87M | -45.32%10.97M |
| Depreciation amortization depletion | -22.82%2.66M | -25.64%2.84M | ---- | ---- | ---- | --3.44M | --3.82M | ---- | ---- | ---- |
| -Depreciation and amortization | -22.82%2.66M | -25.64%2.84M | ---- | ---- | ---- | --3.44M | --3.82M | ---- | ---- | ---- |
| Other operating expenses | 92.01%-290K | -1,522.41%-4.13M | 650.16%8.38M | 518.16%9.07M | 950.48%2.65M | -662.61%-3.63M | -79.78%290K | -365.33%-1.52M | -661.40%-2.17M | -665.45%-311K |
| Operating profit | 97.27%-441K | 77.79%-6.57M | 17.74%-91.69M | -5.60%-29.67M | -71.21%-16.26M | 55.07%-16.17M | 21.90%-29.58M | 38.32%-111.47M | 14.08%-28.1M | 81.14%-9.5M |
| Net non-operating interest income expense | -25.89%2.99M | -14.97%3.24M | 177.88%14.22M | 12.00%3.26M | 112.70%3.11M | 735.61%4.04M | 1,355.73%3.81M | 867.49%5.12M | 2,568.81%2.91M | 1,281.13%1.46M |
| Non-operating interest income | 2.15%4.19M | 18.67%4.53M | 232.10%17M | 57.03%4.57M | 208.33%4.51M | 749.07%4.1M | 1,355.73%3.81M | 867.49%5.12M | 2,568.81%2.91M | 1,281.13%1.46M |
| Non-operating interest expense | 1,743.08%1.2M | --1.28M | --2.78M | --1.31M | --1.4M | --65K | --0 | --0 | --0 | --0 |
| Other net income (expense) | -1.07M | -6.68M | ||||||||
| Special income (charges) | ---1.07M | ---6.68M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --886K | --5.76M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less:Other special charges | --186K | --919K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 112.18%1.48M | 61.16%-10.01M | 27.16%-77.47M | -4.86%-26.42M | -63.65%-13.15M | 65.83%-12.13M | 31.50%-25.77M | 40.98%-106.35M | 22.72%-25.19M | 84.01%-8.04M |
| Income tax | 217.76%756K | 69.50%739K | -69.86%551K | -46.32%459K | -68.76%298K | -7,233.33%-642K | 4,260.00%436K | 140.53%1.83M | 17.77%855K | 11,825.00%954K |
| Net income | 106.28%722K | 58.98%-10.75M | 27.88%-78.02M | -3.18%-26.88M | -49.59%-13.45M | 67.64%-11.49M | 30.36%-26.21M | 40.22%-108.18M | 21.84%-26.05M | 82.11%-8.99M |
| Net income continuous Operations | 106.28%722K | 58.98%-10.75M | 27.88%-78.02M | -3.18%-26.88M | -49.59%-13.45M | 67.64%-11.49M | 30.36%-26.21M | 40.22%-108.18M | 21.84%-26.05M | 82.11%-8.99M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 106.28%722K | 58.98%-10.75M | 27.88%-78.02M | -3.18%-26.88M | -49.59%-13.45M | 67.64%-11.49M | 30.36%-26.21M | 40.22%-108.18M | 21.84%-26.05M | 82.11%-8.99M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 106.28%722K | 58.98%-10.75M | 27.88%-78.02M | -3.18%-26.88M | -49.59%-13.45M | 67.64%-11.49M | 30.36%-26.21M | 40.22%-108.18M | 21.84%-26.05M | 82.11%-8.99M |
| Basic earnings per share | 112.50%0.01 | 61.11%-0.07 | 28.95%-0.54 | 0.00%-0.18 | -50.00%-0.09 | 68.00%-0.08 | 33.33%-0.18 | 45.71%-0.76 | 28.00%-0.18 | 84.62%-0.06 |
| Diluted earnings per share | 112.50%0.01 | 61.11%-0.07 | 28.95%-0.54 | 0.00%-0.18 | -50.00%-0.09 | 68.00%-0.08 | 33.33%-0.18 | 45.71%-0.76 | 28.00%-0.18 | 84.62%-0.06 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data